{"product_id":"uscap-gynecologic-pathology-masterclass-contemporary-issues-in-light-of-shifting-nomenclature-criteria-and-ancillary-testing-2026","title":"USCAP Gynecologic Pathology Masterclass Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026","description":"\u003cdiv class=\"group-header field-group-div clearfix\"\u003e\r\n\u003cdiv class=\"group-header-inner field-group-div\"\u003e\r\n\u003cdiv class=\"group-course-header-right field-group-div\"\u003e\r\n\u003cdiv class=\"field field-name-title field-type-ds field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_3_5 3_5 fusion-flex-column\"\u003e\r\n\u003cdiv class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"\u003e\r\n\u003cdiv class=\"fusion-text fusion-text-2\"\u003e\r\n\u003cdiv class=\"cme-gallery\"\u003e\r\n\u003cdiv class=\"container\" data-testid=\"cme-gallery\"\u003e\r\n\u003cdiv class=\"grid col-span-full mt-3 lg:mt-0\"\u003e\r\n\u003cdiv class=\"cme-gallery__description has-rich-text col-span-full lg:col-span-9 type-body has-rich-text\"\u003e\r\n\u003ch1\u003eUSCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026 (Videos + Digital Slides)\u003c\/h1\u003e\r\n\u003ch2\u003eComprehensive Updates in Gynecologic Pathology, WHO Classification, Molecular Diagnostics, Biomarker Testing, and Precision Gynecologic Oncology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eStay current with the rapidly evolving field of gynecologic pathology through the \u003cstrong\u003eUSCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026\u003c\/strong\u003e, an advanced continuing medical education (CME) program developed by the \u003cstrong\u003eUnited States and Canadian Academy of Pathology (USCAP)\u003c\/strong\u003e. This comprehensive masterclass provides practicing pathologists and pathology trainees with an in-depth review of the latest diagnostic criteria, classification systems, molecular pathology advances, and biomarker testing that are transforming the diagnosis and management of gynecologic malignancies.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReleased on \u003cstrong\u003eJuly 1, 2026\u003c\/strong\u003e, this course is designed around the major updates introduced in the \u003cstrong\u003e6th Edition of the World Health Organization (WHO) Classification of Tumours of Female Reproductive Organs\u003c\/strong\u003e, together with revisions to \u003cstrong\u003eFIGO staging\u003c\/strong\u003e, \u003cstrong\u003eInternational Collaboration on Cancer Reporting (ICCR)\u003c\/strong\u003e recommendations, and the latest \u003cstrong\u003eNational Comprehensive Cancer Network (NCCN)\u003c\/strong\u003e clinical guidelines. Through expert-led lectures, challenging case discussions, and integrated digital whole-slide pathology, participants develop practical skills for applying modern diagnostic criteria, interpreting molecular findings, and incorporating biomarker testing into routine pathology practice.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eA unique feature of this masterclass is the inclusion of \u003cstrong\u003edigital whole-slide images (WSI)\u003c\/strong\u003e for every case. Participants can independently review unknown cases before each lecture or study the slides alongside faculty presentations, creating an interactive educational experience that closely simulates real-world diagnostic practice.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eProduct Details\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e USCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eProvider:\u003c\/strong\u003e United States and Canadian Academy of Pathology (USCAP)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOriginal Release Date:\u003c\/strong\u003e July 1, 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eFormat:\u003c\/strong\u003e Videos + Digital Whole Slide Images (WSI)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Level:\u003c\/strong\u003e Advanced\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eCourse Overview\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eGynecologic pathology continues to evolve rapidly as new molecular discoveries, updated classification systems, and precision oncology approaches reshape diagnostic pathology. The introduction of the \u003cstrong\u003eWHO 6th Edition\u003c\/strong\u003e and revisions to international reporting standards require practicing pathologists to adopt new terminology, recognize newly defined disease entities, and incorporate ancillary testing into everyday diagnostic workflows.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis comprehensive masterclass reviews the most significant updates affecting tumors of the female reproductive tract, including ovarian, endometrial, cervical, vulvar, vaginal, mesenchymal, gestational, and sex cord-stromal neoplasms. Faculty members explain how evolving histopathologic criteria, molecular diagnostics, biomarker assessment, and standardized reporting influence diagnosis, staging, prognosis, and therapeutic decision-making.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants also gain practical experience through interactive digital pathology cases that reinforce pattern recognition, differential diagnosis, and evidence-based interpretation of complex gynecologic lesions.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhat You'll Learn\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eAfter completing this course, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eApply the updated \u003cstrong\u003eWHO 6th Edition\u003c\/strong\u003e classification of female reproductive tract tumors.\u003c\/li\u003e\r\n \t\u003cli\u003eIncorporate current FIGO staging systems into diagnostic pathology reporting.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize ICCR reporting recommendations and NCCN clinical guidelines in daily practice.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize newly classified gynecologic neoplasms and evolving diagnostic terminology.\u003c\/li\u003e\r\n \t\u003cli\u003eDetermine when molecular testing is required for accurate diagnosis.\u003c\/li\u003e\r\n \t\u003cli\u003eInterpret biomarker testing for ovarian, endometrial, and cervical cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eApply precision pathology principles to risk stratification and therapeutic decision-making.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove diagnostic confidence through interactive whole-slide pathology review.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eComprehensive Topics Covered\u003c\/h1\u003e\r\n\u003ch2\u003eWHO Classification of Female Reproductive Tumors\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview the latest updates introduced in the \u003cstrong\u003e6th Edition of the World Health Organization Classification of Tumours of Female Reproductive Organs\u003c\/strong\u003e, including revised terminology, newly recognized entities, updated diagnostic criteria, and contemporary disease classification.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eFIGO, ICCR \u0026amp; NCCN Updates\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eGain practical guidance on applying current international standards for gynecologic cancer diagnosis, staging, pathology reporting, and multidisciplinary patient management.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eFIGO staging revisions\u003c\/li\u003e\r\n \t\u003cli\u003eICCR reporting standards\u003c\/li\u003e\r\n \t\u003cli\u003eNCCN guideline updates\u003c\/li\u003e\r\n \t\u003cli\u003eStandardized pathology reporting\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-based clinical recommendations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eEndometrial Pathology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eDevelop expertise in diagnosing endometrial hyperplasia, carcinoma, precursor lesions, and molecular subtypes while integrating modern classification systems and biomarker assessment.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eOvarian Pathology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eReview contemporary diagnostic approaches to epithelial ovarian tumors, borderline tumors, germ cell tumors, and sex cord-stromal neoplasms, with emphasis on molecular profiling and targeted therapies.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eCervical \u0026amp; Lower Genital Tract Pathology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eExplore current classification systems and nomenclature for cervical, vulvar, and vaginal neoplasia, including HPV-associated lesions, precursor abnormalities, and invasive malignancies.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMesenchymal \u0026amp; Non-Epithelial Gynecologic Tumors\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eGain practical insight into the diagnosis of:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMesenchymal tumors\u003c\/li\u003e\r\n \t\u003cli\u003eUterine sarcomas\u003c\/li\u003e\r\n \t\u003cli\u003eSex cord-stromal tumors\u003c\/li\u003e\r\n \t\u003cli\u003eGestational trophoblastic disease\u003c\/li\u003e\r\n \t\u003cli\u003eRare gynecologic neoplasms\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eFaculty explain when molecular testing is essential for establishing a definitive diagnosis according to current WHO criteria.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMolecular Pathology\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eLearn how modern molecular diagnostics are transforming gynecologic pathology.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMolecular classification\u003c\/li\u003e\r\n \t\u003cli\u003eNext-generation molecular testing\u003c\/li\u003e\r\n \t\u003cli\u003eGenomic alterations\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision pathology\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eTargeted therapies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants review situations in which molecular testing directly influences diagnosis, prognosis, and treatment selection.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eBiomarker Testing\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eDevelop confidence in interpreting clinically relevant biomarkers for gynecologic malignancies.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOvarian cancer biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eEndometrial cancer biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eCervical cancer biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003ePredictive biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003ePrognostic biomarkers\u003c\/li\u003e\r\n \t\u003cli\u003eCompanion diagnostics\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eFaculty discuss the expanding role of biomarker testing in personalized cancer therapy.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDigital Pathology \u0026amp; Whole Slide Imaging\u003c\/h2\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eA distinctive component of this masterclass is the interactive digital pathology experience.\u003c\/p\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eParticipants can:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eReview unknown cases before lectures\u003c\/li\u003e\r\n \t\u003cli\u003eStudy high-resolution whole-slide images (WSI)\u003c\/li\u003e\r\n \t\u003cli\u003eCompare interpretations with expert faculty\u003c\/li\u003e\r\n \t\u003cli\u003eStrengthen microscopic diagnostic skills\u003c\/li\u003e\r\n \t\u003cli\u003eImprove pattern recognition\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis practical approach closely simulates routine diagnostic sign-out and board examination preparation.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eLearning Objectives\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eUpon completion of this educational activity, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eApply current WHO classification updates to tumors of the female reproductive tract.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize updated FIGO staging systems, ICCR reporting recommendations, and NCCN guidelines.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize newly classified gynecologic neoplasms and evolving diagnostic terminology.\u003c\/li\u003e\r\n \t\u003cli\u003eDetermine when molecular testing is required for non-epithelial gynecologic neoplasms.\u003c\/li\u003e\r\n \t\u003cli\u003eInterpret biomarker testing for ovarian, cervical, and endometrial cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate molecular pathology and precision medicine into routine diagnostic practice.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove diagnostic accuracy through digital slide interpretation and case-based learning.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eEducational Highlights\u003c\/h1\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eWHO 6th Edition Classification\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologic Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eOvarian Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eEndometrial Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eCervical Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eVulvar \u0026amp; Vaginal Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eFIGO Staging\u003c\/li\u003e\r\n \t\u003cli\u003eICCR Reporting Standards\u003c\/li\u003e\r\n \t\u003cli\u003eNCCN Guidelines\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eBiomarker Testing\u003c\/li\u003e\r\n \t\u003cli\u003ePrecision Oncology\u003c\/li\u003e\r\n \t\u003cli\u003eWhole Slide Imaging (WSI)\u003c\/li\u003e\r\n \t\u003cli\u003eDigital Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eMesenchymal Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eSex Cord-Stromal Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eGestational Trophoblastic Disease\u003c\/li\u003e\r\n \t\u003cli\u003eCase-Based Learning\u003c\/li\u003e\r\n \t\u003cli\u003eInteractive Digital Slides\u003c\/li\u003e\r\n \t\u003cli\u003eContinuing Medical Education (CME)\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy This Course Stands Out\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThe \u003cstrong\u003eUSCAP Gynecologic Pathology Masterclass 2026\u003c\/strong\u003e provides one of the most comprehensive educational reviews available on contemporary gynecologic pathology. Rather than focusing solely on morphology, the course integrates updated WHO classification systems, international reporting standards, molecular diagnostics, biomarker interpretation, and precision oncology into a practical, case-based curriculum. The inclusion of interactive \u003cstrong\u003ewhole-slide digital pathology\u003c\/strong\u003e allows participants to strengthen diagnostic skills through realistic microscopic case review, making this masterclass particularly valuable for both daily practice and board preparation.\u003c\/p\u003e\r\n\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eTarget Audience\u003c\/h1\u003e\r\n\u003cp class=\"isSelectedEnd\"\u003eThis educational activity is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAcademic Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eCommunity Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologic Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eCytopathologists\u003c\/li\u003e\r\n \t\u003cli\u003ePathology Residents\u003c\/li\u003e\r\n \t\u003cli\u003ePathology Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Oncologists\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologic Oncologists\u003c\/li\u003e\r\n \t\u003cli\u003ePhysicians interested in gynecologic oncology and diagnostic pathology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cdiv contenteditable=\"false\"\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eWhy Choose This Course?\u003c\/h1\u003e\r\nWhether you practice academic pathology, community surgical pathology, or are preparing for board examinations, the \u003cstrong\u003eUSCAP Gynecologic Pathology Masterclass: Contemporary Issues in Light of Shifting Nomenclature, Criteria, and Ancillary Testing 2026\u003c\/strong\u003e delivers an exceptional evidence-based review of modern gynecologic pathology. Combining internationally recognized faculty, updated WHO classifications, molecular diagnostics, biomarker interpretation, interactive whole-slide imaging, and practical case discussions, this program equips pathologists with the knowledge and confidence needed to provide accurate diagnoses and support precision oncology.\r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,0,0\"\u003ePathology of Ovarian Epithelial Tumors – C. Blake Gilks, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,1,0\"\u003eMolecular Testing in Ovarian Cancer – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,2,0\"\u003eEndometrial Pathology – Charles “Matt” Quick, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,3,0\"\u003eMolecular Testing in Endometrial Cancer – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,4,0\"\u003eEndometrium – Charles “Matt” Quick, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,5,0\"\u003eMolecular Testing in Mesenchymal and Gestational Trophoblastic Lesions – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,6,0\"\u003eBiomarker Testing in Lower Genital Tract Neoplasia – Ian S. Hagemann, MD, PhD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,7,0\"\u003eOvarian Epithelial Lesions – C. Blake Gilks, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,8,0\"\u003eOvarian Non-Epithelial Lesions – Marisa R. Nucci, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,9,0\"\u003ePathology of Non-Epithelial Ovarian Tumors – Marisa R. Nucci, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,10,0\"\u003eGynecologic Mesenchymal Neoplasia – Brooke E. Howitt, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,11,0\"\u003eMesenchymal Neoplasms – Brooke E. Howitt, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,12,0\"\u003eCervix – Carlos Parra-Herran, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,13,0\"\u003ePathology of the Uterine Cervix – Carlos Parra-Herran, MD\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,14,0\"\u003eVulvo-Vaginal Pathology – Marilyn A. Kinloch, MD, FRCPC\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,15,0\"\u003eVulva – Marilyn A. Kinloch, MD, FRCPC\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,16,0\"\u003eRoundtable: Grey Areas in Endometrial Pathology\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,17,0\"\u003eRoundtable: Grey Areas in Ovarian Pathology\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,18,0\"\u003eRoundtable: Grey Areas in Non-Epithelial Gynecologic Neoplasia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"1,19,0\"\u003eRoundtable: Grey Areas in Lower Genital Tract Pathology\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43113249538146,"sku":"MED-AMB09589","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/USCAP-Gynecologic-Pathology-Masterclass-Contemporary-Issues-in-Light-of-Shifting-Nomenclature-Criteria-and-Ancillary-Testing-2026.jpg?v=1783964500","url":"https:\/\/meducourse.com\/products\/uscap-gynecologic-pathology-masterclass-contemporary-issues-in-light-of-shifting-nomenclature-criteria-and-ancillary-testing-2026","provider":"Meducourse","version":"1.0","type":"link"}